Carbapenemase genes in clinical and environmental isolates of Acinetobacter spp. from Quito, Ecuador

来自厄瓜多尔基多的鲍曼不动杆菌临床和环境分离株中的碳青霉烯酶基因

阅读:1

Abstract

Carbapenem-resistant Acinetobacter spp. is associated with nosocomial infections in intensive care unit patients, resulting in high mortality. Although Acinetobacter spp. represent a serious public health problem worldwide, there are a few studies related to the presence of carbapenemases in health care facilities and other environmental settings in Ecuador. The main aim of this study was to characterize the carbapenem-resistant Acinetobacter spp. isolates obtained from four hospitals (52) and from five rivers (27) close to Quito. We used the disc diffusion and EDTA sinergy tests to determine the antimicrobial susceptibility and the production of metallo β-lactamases, respectively. We carried out a multiplex PCR of gyrB gene and the sequencing of partial rpoB gene to bacterial species identification. We performed molecular screening of nine carbapenem-resistant genes (bla(SPM), bla(SIM), bla(GIM), bla(GES), bla(OXA-23), bla(OXA-24), bla(OXA-51), bla(OXA-58), and bla(OXA-143)) by multiplex PCR, followed by identification using sequencing of bla(OXA) genes. Our findings showed that carbapenem-resistant A. baumannii were the main species found in health care facilities and rivers. Most of the clinical isolates came from respiratory tract samples and harbored bla(OXA-23), bla(OXA-366), bla(OXA-72), bla(OXA-65), bla(OXA-70), and bla(OXA-143-like) genes. The river isolates harbored only the bla(OXA-51) and probably bla(OXA-259) genes. We concluded that the most predominant type of carbapenem genes among isolates were both bla(OXA-23) and bla(OXA-65) among A. baumannii clinical isolates.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。